Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_assertion type Assertion NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_head.
- NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_assertion description "[mSOD1 microglia isolated from ALS mice at disease onset expressed higher levels of Ym1, CD163 and BDNF (markers of M2) mRNA and lower levels of Nox2 (a marker of M1) mRNA compared with mSOD1 microglia isolated from ALS mice at end-stage disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_provenance.
- NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_assertion evidence source_evidence_literature NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_provenance.
- NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_assertion SIO_000772 22735487 NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_provenance.
- NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_assertion wasDerivedFrom befree-20150227 NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_provenance.
- NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_assertion wasGeneratedBy ECO_0000203 NP820315.RAsOwSsxPa4VuFIR65Bai9rVFWS10o46T9m3C_Vd4HqZA130_provenance.